Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Acura Pharmaceuticals patents

Patents where

Current Assignee

Name

Acura Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11554114 Methods and compositions for self-regulated release of active pharmaceutical ingredients	Patent 11554114 was granted and assigned to Acura Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	11554114	January 17, 2023
‌ US Patent 6949645 Process for the production of opiates	Patent 6949645 was granted and assigned to Acura Pharmaceuticals on September, 2005 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	6949645	September 27, 2005
‌ US Patent 9662393 Methods and compositions for self-regulated release of active pharmaceutical ingredient	Patent 9662393 was granted and assigned to Acura Pharmaceuticals on May, 2017 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	9662393	May 30, 2017
‌ US Patent 9320796 Methods and compositions for self-regulated release of active pharmaceutical ingredient	Patent 9320796 was granted and assigned to Acura Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	9320796	April 26, 2016
‌ US Patent 9101636 Methods and compositions for self-regulated release of active pharmaceutical ingredient	Patent 9101636 was granted and assigned to Acura Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	9101636	August 11, 2015
‌ US Patent 11083794 Methods and compositions for self-regulated release of active pharmaceutical ingredient	Patent 11083794 was granted and assigned to Acura Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	11083794	August 10, 2021
‌ US Patent 7201920 Methods and compositions for deterring abuse of opioid containing dosage forms	Patent 7201920 was granted and assigned to Acura Pharmaceuticals on April, 2007 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	7201920	April 10, 2007
‌ US Patent 7510726 Methods and compositions for deterring abuse of opioid containing dosage forms	Patent 7510726 was granted and assigned to Acura Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	7510726	March 31, 2009
‌ US Patent 7476402 Methods and compositions for deterring abuse of opioid containing dosage forms	Patent 7476402 was granted and assigned to Acura Pharmaceuticals on January, 2009 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	7476402	January 13, 2009
‌ US Patent 8409616 Extended release opioid abuse deterrent compositions and methods of making same	Patent 8409616 was granted and assigned to Acura Pharmaceuticals on April, 2013 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	8409616	April 2, 2013
‌ US Patent 7071336 Process for manufacturing opioid analgesics	Patent 7071336 was granted and assigned to Acura Pharmaceuticals on July, 2006 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	7071336	July 4, 2006
‌ US Patent 8101630 Extended release opioid abuse deterrent compositions and methods of making same	Patent 8101630 was granted and assigned to Acura Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	8101630	January 24, 2012
‌ US Patent 7981439 Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof	Patent 7981439 was granted and assigned to Acura Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	7981439	July 19, 2011
‌ US Patent 9757466 Methods and compositions for deterring abuse	Patent 9757466 was granted and assigned to Acura Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	9757466	September 12, 2017
‌ US Patent 10155044 Methods and compositions for deterring abuse	Patent 10155044 was granted and assigned to Acura Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	10155044	December 18, 2018
‌ US Patent 9492443 Abuse deterrent compositions and methods of making same	Patent 9492443 was granted and assigned to Acura Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	9492443	November 15, 2016
‌ US Patent 7348430 Production of opioid analgesics	Patent 7348430 was granted and assigned to Acura Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	7348430	March 25, 2008
‌ US Patent 10004699 Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse	Patent 10004699 was granted and assigned to Acura Pharmaceuticals on June, 2018 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	10004699	June 26, 2018
‌ US Patent 10688184 Methods and compositions for self-regulated release of active pharmaceutical ingredient	Patent 10688184 was granted and assigned to Acura Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	10688184	June 23, 2020
‌ US Patent 8901113 Methods and compositions for deterring abuse			Acura Pharmaceuticals	United States Patent and Trademark Office	8901113	December 2, 2014
‌ US Patent 11197837 Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse	Patent 11197837 was granted and assigned to Acura Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	11197837	December 14, 2021
‌ US Patent 10610497 Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse	Patent 10610497 was granted and assigned to Acura Pharmaceuticals on April, 2020 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	10610497	April 7, 2020
‌ US Patent 11103581 Methods and compositions for self-regulated release of active pharmaceutical ingredient	Patent 11103581 was granted and assigned to Acura Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.	Acura Pharmaceuticals	Acura Pharmaceuticals	United States Patent and Trademark Office	11103581	August 31, 2021
‌ US Patent 6946556 Preparation of opioid analgesics by a one-pot process	Patent 6946556 was granted and assigned to Acura Pharmaceuticals on September, 2005 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	6946556	September 20, 2005
‌ US Patent 6972332 Process for the production of opiates	Patent 6972332 was granted and assigned to Acura Pharmaceuticals on December, 2005 by the United States Patent and Trademark Office.		Acura Pharmaceuticals	United States Patent and Trademark Office	6972332	December 6, 2005

Results per page:

27 results

0 selected

27 results

0 selected